Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review

Since sorafenib was introduced in 2007 for treating advanced hepatocellular carcinoma (HCC), 15 patients have achieved a complete response (CR) in advanced HCC. However, only four of these reports can be regarded as real CRs involving adequate assessments including imaging, serum tumor markers, and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Mol Hepatol
Main Authors: Kim, Tae Suk, Kim, Ji Hoon, Kim, Baek hui, Lee, Young-Sun, Yoo, Yang Jae, Kang, Seong Hee, Suh, Sang-June, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association for the Study of the Liver 2017
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5760007/
https://ncbi.nlm.nih.gov/pubmed/28633200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0070
Oznake: Označite
Brez oznak, prvi označite!
Nalaganje...

Podobne knjige/članki